Abstract
After 20 years the question of immunosuppressives in the management of inflammatory bowel disease is no longer a subject for a debate. The scientific evidence is clear and incontrovertible that these drugs are effective in both Crohn’s disease and ulcerative colitis. The lack of acceptance by the medical community is based on: 1) a failure to carefully review uncontrolled and controlled trials; 2) a lack of personal experience in treating patients with these agents; and 3) an unfounded fear of toxicity which has not been observed. The evidence of efficacy from published controlled and uncontrolled trials will be presented with emphasis on the personal series of Dr. Korelitz and myself.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Bibliography
Sachar DB, Present DH (1978). Immunotherapy in inflammatory bowel disease. Med Clin N Amer 62:173–183.
Kozarek RA, Patterson DJ, Gelfand MD et al (1989). Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann Int Med 110:353–356.
Brynskov J, Freund L, Rasmussen SN et al (1989). A placebo-controlled, double blind randomized trial of cyclosporin therapy in active chronic Crohn’s disease. N Engl J Med 321:845–850.
Mackay IR, Weiden S, Ungar B (1964). Treatment of active chronic hepatitis and lupoid hepatitis with 6-mercaptopurine and azathioprine. Lancet 1:899–902.
Lennard-Jones JE (1981). Azathioprine and 6-mercaptopurine have a role in the treatment of Crohn’s disease. Dig Dis Sci 26:364–368.
Drucker WR, Jeejeebhoy KN (1970). Azathioprine: an adjunct to surgical therapy of granulomatous enteritis. Ann Surg 172:618–625.
Present DH (1981). 6-mercaptopurine and other immunosuppressive agents in the treatment of Crohn’s disease and ulcerative colitis. Gastro Clin of N Amer 1857–71.
Summers RW, Switz DM, Sessions JT Jr (1979). National Cooperative Crohn’s Disease Study: results of drug treatment. Gastro 77:847–869.
Present DH, Korelitz BI, Wisch N et al (1980). Treatment of Crohn’s disease with 6-mercaptopurine. A long term randomized double blind study. N Engl J Med 302:981–987.
Nyman M, Hansson I, Eriksson S (1985). Long term immunosuppressive treatment in Crohn’s disease. Scand J Gastroenterol 20:1197–1203.
Goldstein F (1987). Immunosuppressant therapy of inflammatory bowel disease. J Clin Gastroenterol 9:654–658.
Present DH, Chapman ML, Rubin PH (1988). Efficacy of 6-mercapto-purine in refractory ulcerative colitis (abstract). Gastro 94A:359.
Singleton JW (1981). Azathioprine has a very limited role in the treatment of Crohn’s disease. Dig Dis Sci 26:368–371.
Malchow H, Ewe K, Brandes JW et al (1984). European Cooperative Crohn’s Disease Study: results of drug treatment. Gastroenterol 86:249–266.
Verhave Mr Winter HS, Grand RJ (1987). Efficacy and safety of azathioprine in children with inflammatory bowel disease (abstract). Gastro 92:1682.
Present DH, Meltzer SJ, Krumholz MP. 6-mercaptopurine in the management of inflammatory bowel disease: short and long term toxicity. Annals Internal Medicine; in press. October 1989.
Kinlen LJ (1985). Incidence of cancer in lupoid arthritis and other disorders after immunosuppressive therapy. Am J Med Suppl 1A 2:44–49.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Kluwer Academic Publishers
About this chapter
Cite this chapter
Present, D.H. (1990). Immunosuppressive Drugs: Do They Have Any Role in the Treatment of IBD?. In: Rachmilewitz, D., Zimmerman, J. (eds) Inflammatory Bowel Diseases 1990. Developments in Gastroenterology, vol 11. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1980-8_24
Download citation
DOI: https://doi.org/10.1007/978-94-009-1980-8_24
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7385-1
Online ISBN: 978-94-009-1980-8
eBook Packages: Springer Book Archive